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Abstract
Background: Puerarin, extracted from Radix puerariae, was reported to ameliorate airway inflammation, lung injury
and lung fibrosis induced by paraquat (PQ) in mice. However, effects of Radix puerariae extracts (RPEs) on lung
fibrosis or signalling pathways in PQ-induced lung injury have not been well studied. Therefore, the goals of our
study were to investigate whether Radix puerariae extracts are antifibrotic in a paraquat (PQ) induced lung fibrosis model
in mice and to propose possible mechanisms of action of the RPE effects.
Methods: We used a long-term exposure model of PQ-induced lung fibrosis in mice to evaluate effects of antioxidant-
containing RPE. We examined effects of miR-21 on follistatin-like 1 (Fstl 1) pathways and oxidative stress in the lung.
Gene expression levels of miR-21, Fstl 1, transforming growth factor-β1 (TGF-β1), connective tissue growth factor
(CTGF), collagen-1 and collagen III were measured by real-time PCR. Protein expression levels of Fstl 1(FSTL1), heme
oxygenase-1 (HO-1), nuclear factor erythroid 2p45-related factor-2 (Nrf2), Smad2/3, p38MAPK, nuclear factor-κB 65
(NF-κB65), and matrix metalloproteinase-9 were detected by western blotting. FSTL1 andalpha-smooth muscle
actin (α-SMA) in lung tissue were detected by immunohistochemistry. Malondialdehyde, superoxide dismutase (SOD),
reduced (GSH) and oxidised (GSSH) glutathione and reactive oxygen species levels, hydroxyproline and total lung
collagen were also determined.
Results: Long-term challenge with PQ enhanced miRNA-21 (miR-21), Fstl 1 pathways, oxidative stress and development
of fibrotic features in the lungs. RPE reduced features of lung fibrosis by blocking Fstl 1 pathways and oxidative stress
through decreased miR-21 expression. This was accompanied by suppression of CTGF, TGF-β1, vascular endothelial
growth factor, collagen I, and collagen III. In addition, PQ-induced activation of NF-κB, Nrf2 and α-SMA were enhanced
by puerarin. We also found that puerarin increased HO-1, SOD and GSH levels.
(Continued on next page)
* Correspondence: zhangwei7222@126.com; qianchuayun@126.com
†Equal contributors
1Department of Emergency, the First Affiliated Hospital of Kunming Medical
University, 295 Xichang Road, Wu Hua District, Kunming 650032, China
Full list of author information is available at the end of the article
© 2016 Liu et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Liu et al. BMC Complementary and Alternative Medicine  (2016) 16:11 
DOI 10.1186/s12906-016-0991-6
(Continued from previous page)
Conclusions: These findings demonstrated that RPEs blocked PQ-induced Fstl 1 pathways and oxidative stress by
inhibiting miR-21 expression, leading to attenuation of PQ-induced lung fibrosis.
Keywords: Lung fibrosis, Radix puerariae extracts, miR-21, Connective tissue growth factor, Nuclear factor erythroid
2p45-related factor-2, Nuclear factor-κB, Oxidative stress, Mice
Background
Paraquat, (PQ) widely used as an herbicide, is controver-
sial because of the high mortality of PQ exposure, with a
typical case fatality of 50–90 % [1]. The major cause of
death by PQ poisoning is respiratory failure, a conse-
quence of oxidative injury to the alveolar epithelium [2].
The primary organ system affected by PQ toxicity is the
lung, where PQ is accumulated via an active transport
process into Clara cells and alveolar type I and type II epi-
thelial cells. Its initial effects are pulmonary oedema, infil-
tration of inflammatory cells and damage to the alveolar
epithelium, followed by the resulting lung fibrosis and re-
spiratory failure [2–4]. The high fatality of PQ is caused
by its inherent toxicity and the lack of any effective treat-
ment [2]. Overall mortality remains above 50 % even in in-
tensive care facilities [2].
The traditional Chinese herbal medicine Radix puer-
ariae has been used to treat alcoholism for thousands
of years [5, 6]. In a recent report, puerarin, extracted
from Radix puerariae, had antioxidant and antithrom-
botic effects and decreased cell injuries caused by lipid
peroxidation by stabilising cell membranes [7–9]. Such
findings indicated that puerarin might prevent PQ-
induced pulmonary fibrosis.
MicroRNAs (miRNAs) are a class of non-coding small
RNAs, 18–22 nucleotides in length, which bind to target
genes and suppress their translation and/or induce deg-
radation of the target gene mRNA. miRNA-21 (miR-21)
is one of the most important miRNAs upregulated dur-
ing fibrogenesis in various tissues [10]. TGF-β1 cansti-
mulate miR-21 expression, detected in the liver, heart,
kidneys and lungs of mice [10]. miR-21 is upregulated in
the lungs of patients with idiopathic pulmonary fibrosis
(IPF) and inhibition of miR-21 attenuates lung fibrosis in
mice [11, 12].
Follistatin-like 1 (FSTL1, coded by the Fstl 1 gene), an
extracellular glycoprotein, was originally cloned from an
osteoblastic cell line as a TGF-βl inducible gene [13].
FSTLl is highly homologous to follistatin, which is ef-
fective against acute lung injury and bleomycin-induced
lung fibrosis by blocking activin and TGF-β [14]. The
physiological function of FSTL1 remains unclear.
TGF-β1 is known to enhance fibrosis by increasing fibro-
blast growth and collagen deposition and promoting differ-
entiation of fibroblasts into myofibroblasts [15], which
secrete collagen and other extracellular matrix components.
CTGF acts as a cofactor with TGF-β1 to induce fibroblasts
to become myofibroblasts, leading to collagen deposition
and ultimately resulting in organ scarring and fibrosis [16].
Oxidative stress is one important molecular mechanism
underlying fibrosis in a variety of organs, including the
lungs [17]. The lungs and all other organs express a wide
variety of antioxidants to protect them against oxidative
stress. These include catalase, GSH, SOD and HO-1. In
addition, Nrf2 is a transcription factor regarded as being
the “master regulator” of the antioxidant response [17].
In this study, we demonstrated that antioxidants present
in a Radix puerariae extract (RPE) could alter pulmonary
fibrosis. We also further explored the underlying signalling
pathways of these anti-fibrotic effects using long-term PQ
exposure in mice as a model system. We found that RPE
ameliorated lung fibrosis and blocked reactive oxygen spe-
cies (ROS)-associated Fstl 1 activation, oxidative stress




Radix puerariae, the root of Pueraria lobata (Willd) Ohwi
(Shanghai Leiyunshang Pharmaceutical Co. Ltd., Shanghai,
China) was ground, extracted three times with 70 % alco-
hol for 2 h, concentrated with a vacuum rotary evaporator
and freeze-dried. The dried powder was then dissolved in
distilled water and filtered. It was chromatographed on a
macroporous resin D101 column (11.5 cm × 85.5 cm)
eluted with distilled water followed by 70 % ethanol. The
70 % ethanol eluate was dried with a rotary evaporator
and stored in the dark at 4 °C. A yield of 3.89 g RPE was
obtained from 100 g of dried Radix puerariae.
Extraction and analysis of Radix puerariae
The dried powder sample (200 mg) of RPE was extracted
with 5 mL methanol for 12 h on a test tube rotator and
centrifuged at 2000 × g for 10 min and the supernatant
collected and evaporated in a Speed-Vac sample concen-
trator (model SPD 111 V, Thermo Savant, LaJolla, CA,
USA). For HPLC analysis, extracts were redissolved in
HPLC grade methanol and filtered through a nylon filter
(0.45 μm, National, Salt Lake City, UT, USA). Sample in-
jection volume for HPLC was 20 μL. The HPLC system
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was equipped with a pump (L2130; Hitachi, Tokyo, Japan),
auto sampler (L-2200; Hitachi) and a UV detector (L-
2400; Hitachi) controlled with “Lachrome Elite” software
(Waters 2487 instrument software).
HPLC separation was performed on a 250 mm × 4 mm
C18 reversed-phase column (5 μm, LichroCART; Merck
KGaA, Darmstadt, Germany) protected by a guard col-
umn of the same material. The HPLC method was as
described by Goyal and Ramawat [8] with small modifi-
cations. The solvent system was composed of solvent A
(0.0025 % trifluoroacetic acid in water) and solvent B
(80 % acetonitrile (E. Merck, Mumbai, India) in solvent
A). The column was eluted with successive gradients of
solvent A and solvent B, with the percent solvent A pro-
grammed as follows: 0–2 min, 85 %; 2–5 min, 85 %→
80 %; 5–15 min, 80 %→ 50 %; 15–20 min, 50 %→ 40 %;
20–30 min, 40 %→ 30 %; 30–35 min, 30 %→ 20 %; 35–
45 min, 20 %→ 0 %; 45–48 min, 0 %; 48–50 min,
0 %→ 85 %; 50–55 min, 85 %. Separation was performed
at a flow rate of 1.0 mL/min and chromatographic peaks
at 254 nm were monitored. The compounds were quanti-
fied from a calibration curve constructed with standard
solutions. To analyse components of RPE, the concentra-
tions of the chemical reference substance standards used
for plotting the calibration curve ranged from 1.0 to
5.0 μg. Each HPLC run was repeated three times.
The HPLC analysis indicated that 100 mg RPE con-
tained 49.4 mg puerarin, 1.3 mg daidzin, and 0.16 mg
daidzein, indicating that puerarin was its major compo-
nent (Fig. 1).
Animals
C57BL/6J (B6) mice were purchased from Kunming Med-
ical University Laboratory Animal Center (Kunming,
China). All mice were housed in the Animal Care Facility
of Kunming Medical University and maintained in a
pathogen-free environment. The mice (8–9 week old and
weighing 20–30 g) used in the experiment were housed in
a vivarium maintained at 23 °C with a 12:12 h light/dark
cycle (lights off at 7.00 p.m.). They received a standard la-
boratory diet and water ad libitum. All experiments were
approved by the Ethics Committee of Kunming Medical
University (Yunnan, China) (Approval number: TCM-
2011-041-E17) and performed according to The Guide-
lines of the Animal Care Committee of Kunming Medical
University.
In vivo miR-21 knockdown using locked nucleic
acid-modified anti-miR-21
Locked nucleic acid (LNA)-modified scrambled or anti-
miR-21 oligonucleotides (Exiqon, Woburn, MA, USA) were
diluted in saline (5 mg/mL) for administration through in-
traperitoneal (i.p.) injection (10 mg/kg) at least 30 min be-
fore PQ exposure [18].
Reagents
PQ aqueous solution (active ingredient content of 200 g/
L, product license number: XK13-003-00058) was from
Chuandong Agrochemical Co., Ltd, (Guangdong, China).
An enhanced chemiluminescence (ECL) kit was from
Perkin Elmer Life Sciences, Inc. (Boston, MA, USA).
SYBR fluorescence quantitative reverse transcription poly-
merase chain reaction (PCR) kit was from Takara Com-
pany (Tokyo, Japan). TRIzol reagent was from Invitrogen
Corporation (Carlsbad, CA, USA), Mouse TGF-β1 and
MMP-9 ELISA kits were from Bender Medsystem (Vienna,
Austria).
Animal treatments
In the first experiment, mice were weighed and randomly
divided into five groups (five mice per group) to assess pro-
tective effects of puerarin on pulmonary fibrosis. For in-
duction of pulmonary fibrosis, PQ (10 mg/kg) or saline, as
a control, was injected i.p. into mice [3]. Group 1 was un-
treated (or, where indicated, received only saline) and
served as the control group; Group 2 received PQ (10 mg/
kg) to induce pulmonary fibrosis and served as the “model
group”; Group 3 received PQ to induce pulmonary fibrosis
Fig. 1 Chromatogram of the chemical reference substances and
sample. a Chromatogram of the chemical reference substances.
b Chromatogram of various samples: 1, hydroxypuerarin; 2, puerarin;
3, daidzin; 4, genistin; 5, daidzein; 6, genistein; 7, formomonetin; 8,
biochanin A
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and was also treated with RPE at a dose of 30 mg/kg i.p.
once per day. On day 14 after PQ injection, mice were
killed and lungs harvested. A small portion of each lung
was fixed with 10 % formalin and embedded in paraffin for
haematoxylin-eosin (HE) and Masson’s trichrome staining.
Real-time PCR analysis
For RNA isolation, lung tissues were frozen in liquid nitro-
gen and stored in a −80 °C freezer until use. Total RNA
was extracted from frozen lung tissue (left lung) with TRI-
zol reagent and amplified with a PCR single-step kit (Pro-
mega, Madison, WI, USA) according to the manufacturer’s
instructions. Real-time-PCR was performed with a PTC-
200 DNA Engine PCR cycler (Bio-Rad Laboratories, Inc.,
Hercules, CA, USA). The primers (Table 1) were designed
based on published sequences of these genes and synthe-
sised by Invitrogen [19, 20]. PCR was performed in a total
volume of 20 μL containing 20 mM Tris–HCl, 50 mM
KCl, 1.25 mM MgCl2, 0.2 mM dNTP, 0.5 mMprimer, 1 U
TaqDNA polymerase and 0.5 μL cDNA. Cycle parameters
were as follows: 95 °C for 3 min, 25 cycles (98 °C for 30 s,
60 °C for 40 s, and 72 °C for 60 s) and 72 °C for 5 min. Or-
dinary PCR products were separated on a 2 % agarose gel.
β2-Actin was used as an endogenous controland values for
each sample were normalised according to its β2-actin
content. The mRNA expression levels of target genes were
calculated using the 2-ΔΔCt method [21, 22].
Western blotting
Lung homogenates were prepared in lysis buffer (50 mM
Tris–HCl, 150 mM NaCl, 1 % NP-40, 0.5 % sodium
deoxycholate, 2 mM NaF, 2 mM EDTA, 0.1 % SDS and a
protease inhibitor cocktail tablet (Roche Applied Sci-
ence, Indianapolis, IN, USA). Protein concentrations
were quantified by the BCA method (Pierce Biotechnol-
ogy, Inc., Rockford, IL, USA). An equal amount of protein
(30 mg) from each sample was loaded on respective gel
lanes. Samples and pre-stained molecular weight markers
(Bio-Rad) were electrophoresed on 12 % Tris-glycine poly-
acrylamide gels, then protein bands were electrophoretic-
ally transferred onto polyvinylidene difluoride (PVDF)
membranes (Millipore Corp., Marlborough, MA, USA).
Membranes were blocked for 1 h at room temperature
with 5 % bovine serum albumin (BSA) and then incubated
overnight at 4 °C with the following primary antibodies:
anti-MMP-9 (Santa Cruz Biotechnology, Dallas, TX, USA),
anti-p-p38MAPK (Bio-Rad Laboratories Inc.), anti-NF-
kB65 (DAKOCorp, Carpinteria, CA, USA), anti-HO-1
(Cell Signaling, Beverly, MA, USA), anti-Nrf2 (Cell Signal-
ing), anti-FSTL1 (R&D systems, Minneapolis, MN, USA),
anti-p-Smad2/3 (Serotec Ltd, Oxford, United Kingdom),
anti-TGF-β1 (Sigma, St. Louis, MO, USA), anti-CTGF
(Santa Cruz Biotechnology), anti-collagen III (Santa Cruz
Biotechnology), anti-collagen-1 (Invitrogen), and anti-β-
actin (Sigma-Aldrich), each diluted 1:1000 in Tris-buffered
saline with Tween-20 (TBST). β-actin blotting served as
the control to confirm protein loading. After washing with
TBST, membranes were incubated with the corresponding
horseradish peroxidase-linked anti-rabbit antibody (Pierce)
diluted in TBST (1:20000) for 1 h at room temperature.
After further washing with TBST, immunoreactive bands
were visualised by enhanced chemiluminescence (ECL)
and quantified by densitometry using Bio-Rad Universal
Hood and Quantity One software (Bio-Rad). Results were
normalised to β-actin levels in the same lanes.
Enzyme-linked immunosorbent assay (ELISA)
At 24 h after the last challenge, bronchoalveolar lavage
(BAL) fluid was obtained from the anaesthetised mice with
1 mL sterile isotonic saline. Lavage was performed four
times and the total volumes pooled for each mouse. Lavage
fluid samples were immediately centrifuged at 2000 × g for
10 min at room temperature and stored at −80 °C until
use. TGF-β1 and MMP-9 levels were then assayed with
TGF-β1 and MMP-9 ELISA kits according to the manufac-
turers’ instructions.
Immunohistochemistry
Immunostaining was performed on lung sections after
antigen retrieval using Retrievagen A (Zymed, South San
Francisco, CA, USA) at 100 °C for 20 min and then
quenching endogenous peroxidases with 3 % H2O2. Sec-
tions were blocked with 2 % BSA in PBS followed by
staining with primary anti-FSTL1 and α-SMA at room
temperature for 1 h. Sections were then washed. After
application of the secondary antibody (Sigma-Aldrich),
tissue staining was developed with Vectastain ABC
(Vector Labs, Burlingame, CA, USA) and 3,3′-
Table 1 Primer sequences for the genes to validate microarray
analysis by real-time-PCR
miRNA-21 F: 5′-TGACATCGCATGGCTGTA-3′ 336 bp
R:5′-GATGCTGGGTAATGTTTGAAT-3′
Fstl1 F: 5′-TTATGATGGGCACrGCAAAGAA-3′ 405 bp
R: 5′- ACTGCCTTTAGAGAACCAGCC-3′
TGF-β1 F: 5′-CAAGAACAAGGCAGACTTATCGC-3′ 418 bp
R: 5′-TCTGATTATCTCGCACCAGGAAG-3
CTGF F: 5′-TTCGGTGGTACGGTGTACCGCA-3′ 359 bp
R: 5′-ACGAACGTCCATGCTGCACAGG-3′
collagen-1 F: 5′-ACCTGCGTACAGAACGGCCT-3′ 318 bp
R: 5′-ACAACACCTTGCCGTTGTCGC-3′
Collagen III F: 5′-GGATCTGTCCTTTGCGATGAC-3′ 276 bp
R: 5′-GCTGTGGGCATATTGCACAA-3′
β-actin F: 5′-CCTCATGAAGATCCTGACCG-3′ 190 bp
R: 5′-ACCGCTCATTGCCGATAGTG-3′
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diaminobenzidine (Vector Labs). With Image Pro Plus
image analysis software (Media Cybernetics, Bethesda,
MD, USA), FSTL1 and α-SMA positive staining in lung tis-
sue were determined and each staining intensity was
expressed as positive units.
Total lung collagen
Total lung collagen was determined by measuring total
soluble collagen (Sircol Collagen Assay, Biocolor, Belfast,
Northern Ireland). The left lung was homogenised in
5 mL 0.5 M acetic acid containing pepsin (1 mg/10 mg tis-
sue; Sigma-Aldrich) and incubated (24 h, 24 °C, with mix-
ing at 240 rpm). Sircol dye was added (1 mL/100 mL, with
mixing for 30 min) and then the sample was centrifuged
(12,000 × g for 12 min). The pellet was resuspended in
1 mL 0.5 M NaOH. The optical density at 540 nm was
measured with a spectrophotometer.
Measurement of intracellular ROS
ROS were measured as previously described [23]. BAL
cells were washed with PBS and incubated for 10 min at
room temperature with PBS containing 3.3 μM 2′,7′-
dichlorofluorescein (DCF) diacetate (Molecular Probes,
Eugene, OR, USA) to label intracellular ROS. DCF
stained cells were analysed by fluorescence-activated cell
sorting (1 × 104 cells).
SOD activity assay
SOD activity was estimated as described by Kakar et al.
[24]. The reaction mixture contained 0.1 mL phenazine
methosulphate (186 μM) and 1.2 mL sodium pyrophos-
phate buffer (0.052 mmol, pH 7.0). Lung homogenate
was prepared in 10 mL ice-coldlysis buffer (50 mM
phosphate buffer with 1 m Methylene diamine tetraace-
tic acid (EDTA) per g tissue and centrifuged twice (once
at 1500 × g for 10 min, and the supernatant centrifuged
again at 10,000 × g for 15 min). An aliquot (0.3 mL) of
the resulting supernatant was added to the reaction mix-
ture. The enzymatic reaction was initiated by adding
0.2 mL NADH (780 μmol) and stopped after 1 min by
adding 1 mL glacial acetic acid. The amount of chromo-
gen formed was measured by absorbance at 560 nm. Re-
sults are expressed in units/mg protein.
Measurement of malondialdehyde (MDA)
Lung tissue homogenates from control and experimental
groups were prepared in 0.1 M Tris–HCl buffer (pH 7.4)
at 4 °C. The resulting tissue homogenates were used for
all biochemical measurements unless otherwise indi-
cated. MDA content was determined by a colorimetric
assay with a commercially available kit (Jiancheng Bio-
engineering Institute, Nanjing, China) according to the
manufacturer’s instructions. Briefly, MDA content in the
lung was measured according to the thiobarbituric acid
method based on the formation of a red complex when
MDA reacted with thiobarbituric acid. The absorbance
was spectrophotometrically measured at 532 nm.
Measurement of GSH and GSSG in lung tissues
Lung tissues were homogenised with 10 mL ice-cold buf-
fer (50 mM phosphate buffer containing 1 mM EDTA per
gram tissue). After centrifugation at 10,000 × g for 15 min
at 4 °C, the supernatants were removed, deproteinated
with 7.5 μl 5 M KOH per 500 μl volume and then stored
at −20 °C until assayed. Total GSH and GSSG levels were
determined with a GSH Assay Kit (Cayman Chemical
Company, Ann Arbor, MI, USA) according to the manu-
facturer’s protocol.
Hydroxyproline assay
Collagen content was determined based on hydroxypro-
line (HYP) levels [25]. Briefly, 10 mg lung tissue was
minced in 1 mL 6 M HCl, hydrolysed and then incubated
overnight at 120 °C. Five milliliters 0.5 M acetic acid was
added and the pH adjusted to between 6.0 and 6.5 with
0.2 M NaOH. Chloramine T solution (1 mL, 0.05 M) was
added and the mixture was incubated for 20 min at room
temperature. Aldehyde-perchloric acid (1 mL of a 0.5 M
solution) was added and the mixture incubated at 60 °C
for 15 min. Absorbance was then recorded at 550 nm. Re-
sults are expressed as μg/mg wet lung weight with HYP
values read from a standard curve.
Histopathology
Whole lungs were inflated in situ with PBS-buffered for-
malin (4.5 %, pH 7.0) (Roth, Darmstadt, Germany) and
then carefully immersed in more PBS-buffered formalin.
Lung tissue samples were paraffin-embedded and 5-μm-
thick sections were prepared and stained with haema-
toxylin/eosin (H/E) and Masson’s or Elastica-van-Gieson
staining. The degree of lung fibrosis was assessed in lung
samples as described by Ashcroft and colleagues [26]
with a numerical scaling system. In the scaling system, 0
indicates normal lung and eight indicates total fibrous
obliteration of the field. Mean lung fibrosis degree, as
defined by Ashcroft et al. [26], was calculated from indi-
vidual scores of~15 microscopic fields analysed per
mouse lung.
Statistical analysis
All values were expressed as the means ± standard devi-
ation (SD) or means ± standard error of the mean (SEM),
as indicated in the individual figure legends. A one-way
ANOVA followed by the Student-Newman-Keuls test was
used to compare the differences among multiple groups.
Pulmonary fibrosis scores were compared using nonpara-
metric methods. The significant level was defined by a P
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value of 0.05. The SPSS 13.0 software package (SPSS, Inc.,
Chicago, IL, USA) was used for statistical analyses.
Results
Effect of miR-21 knockdown on miR-21 expression in lungs
from PQ-treated mice
We investigated effects of miR-21 knockdown on miR-21
expression in lung tissue from mice treated with PQ.
Groups of mice were treated with PQ for 14 d to induce
pulmonary fibrosis. This pulmonary fibrosis model was
established in both miR-21 knockdown and wild-type
(WT) mice. miR-21 expression in pulmonary tissue was
determined by real-time PCR. As shown in Fig. 2, real-
time PCR demonstrated no miR-21 expression in lungs
from the miR-21 knockdown mice, that is, those that had
been treated with the anti-miR-21 oligonucleotides.
miR-21 knockdown decreased FSTL1 expression and
mitigated PQ-induced pulmonary fibrosis
Western blotting was performed to observe the effect of
miR-21 knockdown on FSTL1 protein levels in PQ-
induced pulmonary fibrosis. As shown in Fig. 3, after PQ
treatment, lung expression of FSTL1 was increased and
pulmonary fibrosis exacerbated in miR-21 knockdown
and wild-type (WT) mice. However, protein expression
of FSTL1 was significantly decreased and pulmonary
fibrosis was attenuated in the miR-21 knockdown mice,
as compared with in WT mice.
RPE blocked miR-21, FSTL1, p-p38MAPK, NF-kB65, p-Smad2/
3 and matrix metalloproteinase 9 (MMP-9) expression in
lungs from PQ-treated mice
To assess effects of RPE in PQ-induced lung fibrosis,
we measured miR-21 and FSTL1 gene expression with
real-time PCR and p-p38MAPK, NF-kB65, p-Smad2/3
and MMP-9 protein expression with western blotting
in lung tissue from mice on day 14 after PQ chal-
lenge. As shown in Fig. 4, expression levels of miR-
21, FSTL1, p-p38MAPK, NF-kB65, p-Smad2/3 and
MMP-9 in the lung were increased during PQ-
induced pulmonary fibrosis. In mice also treated with
RPE, expression of all these genes was significantly
decreased.
RPE treatment downregulated expression of TGF-β1,
CTGF, collagen III and collagen I in the lung
To clarify effects of RPE on the expression of TGF-
β1, CTGF, collagen III and collagen I genes under
challenge by PQ, mRNA and protein expressions of
TGF-β1, CTGF, collagen III, and collagen I were mea-
sured by real-time PCR and western blotting, respect-
ively. The mRNA and protein expression levels of
Fig. 2 Effect of miR-21 knockdown on miR-21 expression in lungs from PQ-treated mice. Groups of mice were treated with PQ for 14 days to
induce pulmonary fibrosis.miR-21 expression in pulmonary tissue was determined using real-time PCR. a Typical patterns of miR-21 expression as
assessed by real-time PCR (a, control (scrambled oligonucleotide) group; b, miR-21 knockdown group; c, wild type group); b Statistical analysis of
miR-21 expression. Data are means ± SD from triplicate experiments. *P < 0.05 vs control group; #P < 0.05 vs miR-21 knockdown group
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TGF-β1, CTGF, collagen III and collagen I in the
mouse lung were significantly increased during PQ-
induced pulmonary fibrosis (P < 0.05, Figs. 5, 6). How-
ever, these mRNA (Fig. 5) and protein (Fig. 6) expres-
sion levels were significantly decreased in mice
treated with RPE (P < 0.05).
RPE treatment increased HO-1 and Nrf2 protein expression
in the lung
To observe effects of RPE on expression of HO-1 and
Nrf2 proteins in the lungs in PQ treated mice, we used
western blotting. Protein levels of HO-1 and Nrf2 in the
lung were significantly decreased during PQ-induced pul-
monary fibrosisbut were significantly higher in mice also
treated with RPE (Fig. 7).
Effects of RPE treatment on FSTL1 and α-SMA staining in
lungs from PQ-treated mice
Immunohistochemical analysis was used to determine
distribution of FSTL1 and α-SMA in the mouse lung
on day 14 after PQ or saline treatment. Staining for
FSTL1 and α-SMA was localised to alveolar epithelium.
The number of cells expressing FSTL1 and α-SMA was
significantly increased during PQ-induced pulmonary
fibrosis and this increase was significantly reduced by
RPE treatment (Fig. 8).
RPE treatment decreased TGF-β1 and MMP-9 levels in
BAL from PQ-treated mice
BAL fluids were collected 24 h after PQ treatment to
evaluate levels of MMP-9 and TGF-β1. PQ caused
Fig. 3 Effect of miR-21 knockdown on FSTL1 expression and PQ-induced pulmonary fibrosis. On day 14 after administration of RPE and PQ challenge,
FSTL1 expression and pulmonary fibrosis were assessed. a and b Histopathological changes in lung tissues from mice (a: HE staining, 200× magnification;
b: Masson’s trichrome staining, 200× magnification; a, control (scrambled oligonucleotide); b, miR-21 knockdown; c, WT); c: Representative western blots
showing FSTL1 levels (a, control (scrambled oligonucleotide); b, miR-21 knockdown; c, WT) and statistical analysis of FSTL1 protein levels. Data are
expressed as means ± SEM. *P < 0.05, vs the control group; #P< 0.05 vs the miR-21 knockdown group. d Statistical summary of pulmonary fibrosis scores
in mice. Pulmonary fibrosis scores and levels of FSTL1 expression were expressed as means ± SD from triplicate experiments. *P< 0.05 vs the control
group; #P< 0.05 vs the miR-21 knockdown group
Liu et al. BMC Complementary and Alternative Medicine  (2016) 16:11 Page 7 of 15
significant pulmonary fibrosis, as indicated by increased
BAL concentrations of TGF-β1 and MMP-9. Treatment
of mice with RPE reduced the increases in TGF-β1 and
MMP-9 levels (Fig. 9).
RPE treatment ameliorated oxidative stress
To analyse effects of RPE on oxidative stress, SOD activity
and levels of ROS, MDA, GSH and GSSG were deter-
mined. As shown in Fig. 10, ROS, MDA and GSSG levels
were significantly increased and GSH levels and SOD ac-
tivity were markedly decreased on day 14 after PQ admin-
istration. However, RPE treatment significantly attenuated
these indicators of oxidative stress.
RPE administration attenuated PQ-induced pulmonary
fibrosis
We assessed effects of RPE treatment on PQ-induced pul-
monary fibrosis using histological staining. Masson’s tri-
chrome and H&E staining revealed significant thickening
of alveolar septa and collagen deposition in the lungs on
day 14 after PQ administration (Fig. 11a and b). The degree
of PQ-induced pulmonary fibrosis was greatly attenuated
in mice also treated with RPE.
Dense fibrosis with prominent collagen deposition
was observed in the lungs on day 14 after PQ adminis-
tration. The degree of dense fibrosis with collagen de-
position induced by PQ was greatly attenuated by RPE
treatment (Fig. 11a–c). No abnormal alveolar architec-
ture was observed in lungs of the saline-administered
control mice.
Next, we assessed the degree of pulmonary fibrosis
using a scoring method. In PQ-treated mice, the scores of
fibrotic lesions were significantly worse (that is, higher
scores) on day 14 after PQ administration compared with
those of saline-administered controls (Fig. 11c). However,
the scores were significantly improved by RPE administra-
tion to PQ-treated mice.
Based on measurements of lung HYP content, we
further assessed the degree of pulmonary fibrosis, ob-
serving a significant increase on day 14 after PQ ad-
ministration (Fig. 11c). However, HYP content was
significantly lower in PQ-treated mice that had also re-
ceived RPE (Fig. 11c).
Fig. 4 Effects of RPE on miR-21, FSTL1, p-p38MAPK, NF-kB65, p-Smad2/3, and MMP-9 expression in lungs from mice treated with PQ. On day 14
after administration of RPE and PQ challenge, miR-21, FSTL1, p-p38MAPK, NF-kB65, p-Smad2/3 and MMP-9 expression were assessed by real-time
PCR (a) and p-p38MAPK, NF-kB65, p-Smad2/3 and MMP-9 protein levels by western blotting (b) Groups are as defined in Methods. (a, control; b,
model group; c, treatment group). Values are means ± SD as determined from three independent experiments. *P < 0.05 and **P < 0.01 vs the control
group; # P < 0.05 and # # P < 0.01 vs the model group. (The “model group” for PQ-induced lung fibrosis is defined in Methods.)
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Fig. 6 Effect of RPE treatment on protein expression of TGF-β1, CTGF, collagen III and collagen I in the lung. a Representative western blots showing
expression levels of TGF-β1, CTGF, collagen III and collagen I in mice on day 14 after administration of RPE (a, control group; b, model group; c, treatment
group). b Statistical summary of the densitometric analyses of protein expression in mice. Data are the means ± SD as determined from three independent
experiments. *P< 0.05 and**P< 0.01 vs the control group; # P< 0.05 and # # P< 0.01 vs the model group
Fig. 5 Effects of RPE treatment on gene expression of TGF-β1, CTGF, collagen III and collagen I in the lung. a Representative real-time PCR showing
expression levels of TGF-β1, CTGF, collagen III and collagen I in mice on day 14 after the administration of RPE (a, control group; b, model group; c,
treatment group). b Statistical summary of the 2^(−delta delta ct) analyses on mRNA expression in mice. Data are the means ± SD as determined from
three independent experiments. *P < 0.05 and**P < 0.01 vs the control group; # P < 0.05 and # # P < 0.01 vs the model group
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Discussion
The herbicide PQ primarily accumulates in the lungs
through the highly developed polyamine uptake system,
leading to the generation of a superoxide radical (O2
−)
through oxygen- and NADPH-dependent redox cycling
and resulting in acute oxidative stress-related insults
[27, 28]. Current treatments for PQ poisoning focus on re-
ducing its absorption from the gastrointestinal tract and on
increasing its elimination [29]. Several other interventions
have been proposed but none were shown to be effective
in clinical trials. The most potentially promising interven-
tion is immunosuppressive therapy but it is not widely
used because it has little supporting evidence [29, 30].
Puerarin has been reported to have protective effects
related to its abilities to increase SOD activity, decrease
lipid peroxidation and enhance fibrinolysis [31]. Puerarin
is a scavenger of oxygen-free radicals and can prophylactic-
ally reduce the oxidative injury induced by H2O2 and
superoxide anion [32]. Recent studies indicated that puer-
arin inhibited oxidative stress induced by acute alcoholism
[33], reduced PGE2, TNF and IL-6 production [34] and
acted as an anti-inflammatory agent by blocking NF–kappa
B signalling [34]. It was suggested that puerarin should be
developed for chemoprevention of atherosclerosis [35]. In
our study, RPE, extracts that contain puerarin, inhibited
miR-21 expression, blocked FSTL1 expression and in-
creased HO-1 and Nrf2 protein levels in lungs from
PQ-treated mice. RPE treatment also inhibited PQ-
induced effects on ROS and MDA levels, downregulated
gene expression of TGF-β1, CTGF, collagen III and colla-
gen I and ameliorated PQ-induced pulmonary fibrosis.
These results support an important role of puerarin in at-
tenuating development of pulmonary fibrosis or protect-
ing against pulmonary fibrosis after PQ exposure.
Because miR-21 is one of the most abundant micro-
RNAs, it plays an important role in the pathogenesis and
development of fibrosis. Previous studies indicated that
miR-21 was upregulated during fibrogenesis in the heart,
kidney and lung [36–38]. In addition, miR-21 was signifi-
cantly upregulated during liver fibrosis of different aetiol-
ogies [39], further indicating that miR-21 is a common
effector in fibrotic disease. This implies that miR-21 is an
attractive potential therapeutic target against fibrosis under
various pathological conditions. Upregulation of miR-21
was observed in the cardiac fibroblasts of failing hearts and
treatment with an miR-21 antagomir in amouse model of
cardiac hypertrophy prevented interstitial fibrosis and im-
proved cardiac function [40]. Inhibiting miR-21 expression
Fig. 7 Effect of RPE treatment on protein expression of HO-1 and Nrf2 in the lung. a Representative western blots showing HO-1 and Nrf2 protein
on day 14 after RPE treatment (1, control group; 2, model group; 3, treatment group). b Statistical summary of the densitometric analyses of HO-1
and Nrf2 expression. Data are means ± SD of three experiments. *P < 0.05 and **P < 0.01 vs the control group; ##P < 0.01 and #P < 0.01 vs the
model group
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Fig. 8 Effect of RPE treatment on the protein expression of FSTL1 and α-SMA in the lung. Immunohistochemistry was performed on lung sections
after antigen retrieval with Retrievagen on day 14 after RPE treatment. a Representative immunostaining (brown) patterns for FSTL1 and α-SMA
are shown: FSTL1 staining (a, control group; b, model group; c, treatment group); α-SMA staining (d, control group; e, model group; f, treatment
group). b Statistical summary of the densitometric analyses of FSTL1 and α-SMA staining. Data are means ± SD. *P < 0.05 and **P < 0.01 vs the
control group; ##P < 0.01 and #P < 0.01 vs the model group
Fig. 9 Effect of RPE treatment on levels of TGF-β1 and MMP-9 in BAL. TGF-βand MMP-9 in BALwere measured by ELISA. Data are means ± SD
from triplicate experiments. **P < 0.01 and *P < 0.05 vs the control group; # P < 0.05 and # # P < 0.01 vs the model group
Liu et al. BMC Complementary and Alternative Medicine  (2016) 16:11 Page 11 of 15
in the lung successfully ameliorated pulmonary fibrosis
and it was suggested that miR-21 promoted fibrosis by tar-
geting the anti-fibrotic protein Smad7 [41]. Smad7, as an
intrinsic inhibitor of the TGF-β/Smad2/3 pathway, com-
petes with R-Smads for type I TGF receptors (TβRI) and
intervenes in TGF-β/Smad2/3 signal transduction [41]. Pre-
vious studies indicated that adenovirus-mediated Smad7
overexpression in the mouse liver inhibited collagen depos-
ition and α-SMA expression in hepatic stellate cells (HSCs)
[42]. In our study, PQ markedly upregulated miR-21 ex-
pression, stimulated FSTL1 expression, facilitated TGF-β/
Smad2/3 and p38MAPK signal transduction and induced
pulmonary fibrosis. However, administration of RPE signifi-
cantly suppressed PQ-induced miR-21 expression, blocked
FSTL1 expression, decreased p-p38MAPK, NF-kB65, p-
Smad2/3 and MMP-9 protein levels and attenuated pul-
monary fibrosis.
Fstl l was upregulated in patients with IPF and in the
bleomycin-induced model of pulmonary fibrosis [13]. In
the lungs of bleomycin-treated WT mice, Fstl l mRNA
and FSTL1 protein levels were increased and FSTL1 im-
munoreactivity was evident in fibrotic areas [14]. Fstl l
haploinsufficiency in Fstl l +/− mice showed a clear anti-
fibrotic effect in the lungs after bleomycin treatment, as
indicated by a markedly attenuated fibrotic phenotype
with significantly less collagen deposition, as compared
with in wild type mice [14]. These findings confirmed
the critical role of FSTL1 as a profibrotic protein during
progressive interstitial fibrosis [14]. In Fst l+/− mice, in-
sufficiency of FSTL1 attenuated bleomycin-induced fi-
brosis, with limited expansion of the myofibroblast pool
because of impaired epithelial mesenchymal transition
(EMT) and reduced Smad2/3, ERK and JNK phosphoryl-
ation [14]. Fstl l overexpression increased TGF-β1-induced
EMT via Smad-dependent and MAPK-dependent path-
ways in A549 cells. In that study, selective chemical block-
ade of Smad2/3, ERK or JNK phosphorylation decreased
expression of EMT marker proteins [14]. Our study dem-
onstrated that Fstl l was upregulated through miR-21 ex-
pression after PQ challenge, resulting in increased Smad2/
Fig. 10 Effect of RPE treatment on SOD activity and levels of ROS, MDA, GSH and GSSG in the lung. These parameters of oxidative stress were
assessed as described in Methods. Data are means ± SDas determined from three independent experiments. **P < 0.01 and *P < 0.05 vs the
control group; # P < 0.05 vs the model group
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3 and p38MAPK phosphorylation and progressive PQ-
induced pulmonary fibrosis. RPE treatment significantly
downregulated Fstl l expression by decreasing miR-21 ex-
pression. This decreased the expression of profibrogenic
genes and directly suppressed PQ-induced fibrosis.
Smad2/3, as the primary signalling mediator, is pivotal
in the TGF-β signalling pathway. Thus, Smad2/3 medi-
ated expression of type I collagen A1 in activated HSCs
and targeted deletion of Smad2/3 prevented or halted
the progression of hepatic fibrosis in animals [43]. Inter-
estingly, in our present study, puerarin induced down-
regulation of Smad2/3 expression in PQ-treated mice.
This likely reduced expression of profibrogenic genes
and directly suppressed pulmonary fibrosis, thus protect-
ing against miR-21-mediated injury and downregulating
the major signalling transducer, Smad2/3.
CTGF is the primary downstream mediator of TGF-β-
induced fibroblast activation and its specific role in fibrotic
tissue makes it a better therapeutic target than TGF-β [44].
In our study, RPE extracts appeared to attenuate PQ-
induced lung fibrosis through blocking TGF-β1 and CTGF
expression, as a result of decreased miR-21 levels. This
suggested that PQ-induced fibrosis might be mediated by
miR-21-stimulated expression of the profibrotic factors
TGF-β1 and CTGF.
PQ produces lung oxidative stress in animals [2] and
humans [3]. Excessive levels of ROS damage cellular mac-
romolecules, such as DNA, lipids and proteins, leading to
oxidative stress-induced tissue injury [45]. Cellular antioxi-
dants play a key role in removal or detoxification of ROS
and are essential for preventing oxidative damage. HO-1
provides an inducible defence mechanism that can be acti-
vated ubiquitously in cells and tissues in response to nox-
ious stimuli, conferring cellular protection against injury
inflicted by such stimuli [46]. HO-1 may play an important
role in protecting against PQ-induced tissue damage. Nrf2
is a redox-sensitive basic leucine zipper transcription factor
of the NADPH oxidase complex that is activated by
Fig. 11 Effect of RPE treatment on lung histopathology (a: HE staining, 200× magnification; b: Masson’s trichrome staining, 200× magnification).
a and b Histopathological changes in lung tissue from mice (a, control group; b, model group; c, treatment group). c Statistical summary of
pulmonary fibrosis scores in mice. Pulmonary fibrosis scores were analyzed by nonparametric methods from triplicate experiments. **P < 0.01 vs
the control group; #P < 0.05 vs the model group
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oxidative stress and, when activated, translocates into the
nucleus [47]. Nrf2 activation has been reported to play an
important role in the antioxidant response element (ARE)-
driven expression of several detoxifying and antioxidant
enzymes, including HO-1 [48]. In this study, puerarin in-
creased HO-1 and Nrf2 expression, suppressed ROS and
MDA levels, significantly increased SOD activity and GSH
levels, decreased miR-21 and Fstl 1 expression and attenu-
ated PQ-induced pulmonary fibrosis.
TGF-βl induces breakdown of collagen and other matrix
proteins by enhancing generation of MMPs [48] and plas-
minogen activators and inhibiting expression of tissue in-
hibitors of metalloproteinases (TIMPs) [49]. Therefore, in
addition to downregulating miR-21 and Fstl l expression,
puerarin might interrupt the TGF-β autocrine pathway by
inhibiting MMP-9 activity and, thereby, suppress PQ-
induced pulmonary fibrosis.
NF-κB activation increased in an animal model of lung
fibrosis and blocking NF-κB activation suppressed lung
collagen deposition and inflammation, consequently ex-
acerbating fibrosis [50]. Several lines of evidence suggest
that MAPK can participate in NF-κB activation in the
cytoplasm as well as the modulation of its transactivation
potential in the nucleus [51]. In our experiments, RPE
treatment blocked the p38MAPK pathway and inhibited
NF-κB activation by suppressing Fstl 1 expression via
downregulation of miR-21 expression. This reduced lung
collagen deposition and alleviated PQ-induced pulmon-
ary fibrosis.
PQ causes destruction of the lung architecture, leading
to pulmonary fibrosis, which is characterised by increased
HYP levels and more collagen deposition in the lungs [52].
α-SMA is a marker of fibroblast activation and its presence
indicates the occurrence of the fibroblast transition to-
wards myofibroblasts [53]. The present study showed a
substantially increased intensity of lung collagen staining in
PQ-treated animals, reflecting the detrimental alterations
associated with fibrosis. Increased HYP levels were corre-
lated to collagen accumulation in the alveolar space. Our
data also indicated that the RPE-treated mice exhibited sig-
nificantly lower HYP levels and α-SMA expression. The
ameliorating effects of RPE on these histological alterations
indicated suppression of Fstl l mediated effects by down-
regulating miR-21 expression, preventing accumulation of
HYP in lungs of mice treated with PQ.
Conclusions
The results of this study suggest a novel compensatory
mechanism for the action of RPE in inhibiting lung fibrosis
under its pathological induction by PQ. This mechanism
involves blocking profibrotic gene and protein expression
though decreasing Fstl l expression via downregulation of
miR-21. We have demonstrated for the first time that RPE
has protective, antifibrotic effects against pulmonary
fibrosis in a PQ-induced mouse model. Thus, the beneficial
effects of in vivo administration of RPE on the parameters
of pulmonary fibrosis described in this study support a
novel potential therapeutic modality for treating PQ-
induced pulmonary fibrosis and other forms of pulmonary
fibrosis.
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